Helix BioPharma (TSE:HBP) Share Price Passes Below 50 Day Moving Average – What’s Next?

Helix BioPharma Corp. (TSE:HBP) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$1.89 and traded as low as C$1.89. Helix BioPharma shares last traded at C$1.89, with a volume of 110 shares.

Helix BioPharma Price Performance

The company has a current ratio of 0.04, a quick ratio of 1.04 and a debt-to-equity ratio of 2.34. The business has a fifty day simple moving average of C$1.89 and a 200 day simple moving average of C$2.09. The stock has a market capitalization of C$144.35 million, a P/E ratio of -31.50 and a beta of 0.38.

About Helix BioPharma

Helix BioPharma is an oncology company that innovates from strength to bring near-term solutions for today’s hardest-to-treat cancers. The Company’s pipeline is led by Tumor Defense Breaker¿ L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy and augment the effectiveness of today’s front-running anti-cancer treatments. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with Helix’s next-generation bi-specific antibody-drug conjugates (ADCs), currently in discovery.